Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PulsenmorePLSM -6.70%25 Pretax Margin % is 20.27% as of Dec. 2025. GuruFocus rates PLSM with a GF Score™ of 25/100 and a GF Value™ of $8.16 (Possible Value Trap). The stock has 1 warning sign investors should review. Among 818 Medical Devices & Instruments companies, Pulsenmore ranks worse than 73.59% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Pulsenmore's Pre-Tax Income for the
six
months ended in Dec. 2025 was $2.42 Mil. Pulsenmore's Revenue for the
six
months ended in Dec. 2025 was $11.91 Mil. Therefore, Pulsenmore's pretax margin for the quarter that ended in Dec. 2025 was 20.27%.
The historical rank and industry rank for Pulsenmore's Pretax Margin % or its related term are showing as below:
PLSM'
s Pretax Margin % Range Over the Past 10 Years
Min: -1670.47 Med: -380.83 Max: -39.61
Current: -39.61
PLSM's Pretax Margin % is ranked worse than 73.59% of 818
companies
in the Medical Devices & Instruments industry
Industry Median: 2.505
vs PLSM: -39.61
Pulsenmore (NAS:PLSM) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Pulsenmore Pretax Margin % Related Terms
Pulsenmore Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Pulsenmore's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Pulsenmore's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pulsenmore Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pulsenmore's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Pulsenmore's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pulsenmore (PLSM) has a Pretax Margin % of 20.27% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Pulsenmore and its competitors. According to the industry distribution chart, Pulsenmore ranks #602 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 73.6%.
Is Pulsenmore's Pretax Margin % too high?
Pulsenmore's current Pretax Margin % is 20.27%. The Medical Devices & Instruments industry median Pretax Margin % is 2.51. Pulsenmore's value of 20.27% is 709.2% above this industry median. Based on the distribution chart, Pulsenmore ranks #602 out of 818 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Pulsenmore has a GF Score™ of 25/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Pulsenmore's Pretax Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Pulsenmore ranks #602 out of 818 companies for Pretax Margin %. This places Pulsenmore in the lower half of its industry. The industry median Pretax Margin % is 2.51. Pulsenmore's value of 20.27% is 709.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.51, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pulsenmore's current Pretax Margin % of 20.27% is 709.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Pulsenmore and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pulsenmore's current Pretax Margin % is 20.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pulsenmore stock overvalued right now?
Based on GuruFocus' analysis, Pulsenmore (PLSM) is currently considered Possible Value Trap. The stock's GF Value™ is $8.16, compared to a current price of $3.60 — trading 55.9% below its estimated fair value. The current Pretax Margin % is 20.27% and 709.2% above the Medical Devices & Instruments industry median of 2.51. Pulsenmore's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Pulsenmore (PLSM), the current Pretax Margin % is 20.27% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pulsenmore (PLSM) Overvalued in 2026?
Based on GuruFocus' analysis, Pulsenmore stock appears to be undervalued.
The current stock price of $3.60 is trading 55.9% below its estimated GF Value™ of $8.16.
GuruFocus considers Pulsenmore to be Possible Value Trap.
Key valuation signals for PLSM:
Pretax Margin %: 20.27%
GF Value™: $8.16 vs. price of $3.60 (55.9% below fair value)
Industry Position: 709.2% above the Medical Devices & Instruments median (#602 of 818)
No single metric tells the full story. See the PLSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.
25GF Score
Get the complete analysis for PLSM
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLSM has been successfully added to your 
